Abstract

The combination of Bacillus Calmette Guerin (BCG) with anti-COX-2 selective molecules and/or COX-2 preferential FANS for the treatment of pathologies related to the loss of macrophages functions and deficiencies of cell-mediated immunity.


Claims

Information currently unavailable.

Sign in to the Lens